Dr. Öğr. Üyesi Erkan KAYIKÇIOĞLU

1. Real-World Treatment Efficacy of Ribociclib or Palbociclib Plus Fulvestrant in Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study

Kahraman S., Erul E., GÜMÜŞAY Ö., GÜVEN D. C., AKSOY S., BAŞARAN G., et al.

Clinical Breast Cancer , cilt.25, sa.5, 2025 (SCI-Expanded, Scopus)

2. Assessment of polypharmacy, potentially inappropriate medications, and drug-drug interactions in older patients with cancer

ALBAYRAK A., Erbay B., KAYIKÇIOĞLU E.

Journal of Oncology Pharmacy Practice , cilt.31, sa.5, ss.693-699, 2025 (SCI-Expanded, Scopus)

3. Hormon reseptörü pozitif, HER2 negatif metastatik meme kanseri tanısıyla ribosiklib veya palbosiklib ile letrozol kombinasyon tedavisi verilen hastalarda HER2-düşük ekspresyonunun önemi

kahraman s., Hizal M., Gumusay O., Basaran G., Seyyar M., Sahin E., et al.

Turkish Journal of Clinics and Laboratory , cilt.16, sa.2, ss.255-262, 2025 (TRDizin)

4. Cancer Patients’ Attachment Styles in the First Year After Diagnosis: The Impact of Perceived Stress and Emotion Regulation Skills

Yaman G. B., Kayikcioglu E., Hocaoglu C.

Psychiatry and clinical psychopharmacology (Online) , cilt.35, sa.1, ss.22-30, 2025 (SCI-Expanded, Scopus, TRDizin)

5. Real-world data on the efficacy and safety of trastuzumab emtansine in patients with metastatic breast cancer previously treated with pertuzumab: Turkish oncology group multicenter study

Dülgar Ö., Türker S., BAŞARAN G., Araz M., Sümbül A. T., Çağlayan D., et al.

Journal of Chemotherapy , cilt.37, sa.4, ss.334-340, 2025 (SCI-Expanded, Scopus)

6. Machine learning for predicting colon cancer recurrence

KAYIKÇIOĞLU E., Onder A. H., BACAK B., SEREL T. A.

Surgical Oncology , cilt.54, 2024 (SCI-Expanded, Scopus)

7. The efficacy of palbociclib and ribociclib in the first-line treatment of metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer in male patients: a Turkish oncology group (TOG) study

Yıldırım H. Ç., KUTLU Y., Mutlu E., Aykan M. B., Korkmaz M., Yalçın S., et al.

International Journal of Clinical Oncology , cilt.29, sa.3, ss.258-265, 2024 (SCI-Expanded, Scopus)

8. Prognostic value of computed tomography associated body composition measurement changes in metastatic colorectal cancer patients

SEVGİLİOĞLU Z. E., EVRİMLER Ş., İŞCAN G., KAYIKÇIOĞLU E., ŞENGÜL S. S., ÇETİN B.

Acta Radiologica , cilt.64, sa.11, ss.2849-2857, 2023 (SCI-Expanded, Scopus)

9. Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer

KAHRAMAN S., Erul E., Seyyar M., GÜMÜŞAY Ö., Bayram E., Demirel B. C., et al.

FUTURE ONCOLOGY , cilt.19, ss.727-736, 2023 (SCI-Expanded, Scopus)

10. Prognostic value of claudin 18.2 expression in gastric adenocarcinoma.

Kayikcioglu E., Yüceer R. O., Cetin B., Yüceer K., Karahan N.

World journal of gastrointestinal oncology , cilt.15, sa.2, ss.343-351, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

11. Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy.

Karacin C., Oksuzoglu B., Demirci A., KESKİNKILIÇ M., Baytemür N. K., Yılmaz F., et al.

BMC cancer , cilt.23, sa.1, ss.136, 2023 (SCI-Expanded, Scopus)

12. The role of claudin 18.2 and HER-2 in pancreatic cancer outcomes

KAYIKÇIOĞLU E., Yüceer R. O.

Medicine (United States) , cilt.102, sa.6, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

13. A Novel Prognostic Index for Metastatic Colon Cancer: The Prognostic Immune Nutritional Index

KAYIKÇIOĞLU E., İŞCAN G.

CUREUS JOURNAL OF MEDICAL SCIENCE , cilt.15, sa.1, 2023 (ESCI)

14. EXAMINATION OF MENTAL SYMPTOMS, ANGER, AND DEATH ANXIETY IN ELDERLY CANCER PATIENTS

Yaman G. B., KAYIKÇIOĞLU E., HOCAOĞLU Ç.

Turk Geriatri Dergisi , cilt.26, sa.3, ss.302-313, 2023 (SCI-Expanded, SSCI, Scopus, TRDizin)

15. DEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF PATIENTS WITH COLON CANCER IN ISPARTA-BURDUR REGION

Kayikcioglu E.

Süleyman Demirel Üniversitesi Tıp Fakültesi Dergisi , cilt.29, sa.3, ss.386-389, 2022 (TRDizin)

Dr. Öğr. Üyesi Erkan KAYIKÇIOĞLU

Yayınlar & Eserler

1. Real-World Treatment Efficacy of Ribociclib or Palbociclib Plus Fulvestrant in Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study

2. Assessment of polypharmacy, potentially inappropriate medications, and drug-drug interactions in older patients with cancer

3. Hormon reseptörü pozitif, HER2 negatif metastatik meme kanseri tanısıyla ribosiklib veya palbosiklib ile letrozol kombinasyon tedavisi verilen hastalarda HER2-düşük ekspresyonunun önemi

4. Cancer Patients’ Attachment Styles in the First Year After Diagnosis: The Impact of Perceived Stress and Emotion Regulation Skills

5. Real-world data on the efficacy and safety of trastuzumab emtansine in patients with metastatic breast cancer previously treated with pertuzumab: Turkish oncology group multicenter study

6. Machine learning for predicting colon cancer recurrence

7. The efficacy of palbociclib and ribociclib in the first-line treatment of metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer in male patients: a Turkish oncology group (TOG) study

8. Prognostic value of computed tomography associated body composition measurement changes in metastatic colorectal cancer patients

9. Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer

10. Prognostic value of claudin 18.2 expression in gastric adenocarcinoma.

11. Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy.

12. The role of claudin 18.2 and HER-2 in pancreatic cancer outcomes

13. A Novel Prognostic Index for Metastatic Colon Cancer: The Prognostic Immune Nutritional Index

14. EXAMINATION OF MENTAL SYMPTOMS, ANGER, AND DEATH ANXIETY IN ELDERLY CANCER PATIENTS

15. DEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF PATIENTS WITH COLON CANCER IN ISPARTA-BURDUR REGION

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (Scopus)

H-İndeks (Scopus)

Tez Danışmanlığı

Açık Erişim